Vanguard Personalized Indexing Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $5.26 Billion
- Q2 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 19,329 shares of LXRX stock, worth $30,539. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,329
Previous 15,485
24.82%
Holding current value
$30,539
Previous $37,000
13.51%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LXRX
# of Institutions
131Shares Held
240MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4175MShares$277 Million18.64% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$15.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$13.1 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$12.1 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.85MShares$9.24 Million0.24% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $298M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...